Vertex to Announce Fourth Quarter and Full Year 2023 Financial Results on February 5
17 Gennaio 2024 - 2:00PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its fourth quarter and full year 2023 financial results on Monday,
February 5, 2024 after the financial markets close. The company
will host a conference call and webcast at 4:30 p.m. ET. To access
the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651
(International) and reference the “Vertex Pharmaceuticals Fourth
Quarter 2023 Earnings Call.”
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has approved medicines that
treat the underlying causes of multiple chronic, life-shortening
genetic diseases — cystic fibrosis, sickle cell disease and
transfusion-dependent beta thalassemia — and continues to advance
clinical and research programs in these diseases. Vertex also has a
robust clinical pipeline of investigational therapies across a
range of modalities in other serious diseases where it has deep
insight into causal human biology, including APOL1-mediated kidney
disease, acute and neuropathic pain, type 1 diabetes, myotonic
dystrophy type 1 and alpha-1 antitrypsin deficiency.
Vertex was founded in 1989 and has its global headquarters in
Boston, with international headquarters in London. Additionally,
the company has research and development sites and commercial
offices in North America, Europe, Australia, Latin America and the
Middle East. Vertex is consistently recognized as one of the
industry's top places to work, including 14 consecutive years on
Science magazine's Top Employers list and one of Fortune’s 100 Best
Companies to Work For. For company updates and to learn more about
Vertex's history of innovation, visit www.vrtx.com or follow us on
LinkedIn, Facebook, Instagram, YouTube and Twitter/X.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240117256864/en/
Vertex Pharmaceuticals Incorporated Investor Relations:
investorinfo@vrtx.com
Grafico Azioni Vertex Pharmaceuticals (NASDAQ:VRTX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Vertex Pharmaceuticals (NASDAQ:VRTX)
Storico
Da Giu 2023 a Giu 2024